UNSPSC 41141813: Glycosylated/glycated hemoglobin

In this classification, this entry connotes a substrate made of Glycosylated/glycated hemoglobin that is used in clinical chemistry testing.

UNSPSC 41141813 Glycosylated/glycated hemoglobin is a Commodity code that in recent state and local procurement appears to span laboratory reagents, diagnostic consumables, and analytical reference standards used in public health surveillance, clinical testing, and environmental water-quality monitoring rather than hemoglobin measurement alone. State and local health departments and university research centers are the dominant issuing bodies, with the Texas Health and Human Services Commission appearing repeatedly as a high-volume buyer across multiple related test-kit and reagent procurements. The scope of work under this code reflects actual purchasing for next-generation sequencing consumables (respiratory pathogen detection kits, whole genome sequencing reagent bundles), solid-phase extraction disks for EPA drinking-water compliance testing, culture media for foodborne pathogen identification, gas chromatography columns and chemical standards for organic contaminant analysis, and specialized mycobacterial diagnostic reagents—all mission-critical supplies for state and regional public health laboratories.

Recent activity concentrates in Texas, Mississippi, and California, with secondary municipal procurement in Philadelphia. The Texas Health and Human Services Commission has posted at least five IFBs since February 2026 for laboratory consumables and sequencing kits (HHS0016980 Clear Dx Instrument, posted Feb 2026, due Feb 19; HHS0017271 Standards, Consumables and Instrument Parts, due May 12; HHS0017287 Atlantic ReadyDisk HC-C18, due May 13; HHS0017272 Respiratory Panel Kits, due May 19; HHS0017132 Culture Media, due June 2). The Mississippi State Department of Health issued two sole-source procurements in April 2026 for Clear Labs kits and Illumina sequencing reagents (due May 14, totaling $619,739.98 combined). The University of Texas Health Science Center at San Antonio released RFP 745-26-P19 for a comprehensive Biotech Research and Clinical Diagnostics Equipment Catalog (due June 4), and the State of California solicited MyCodeDR reagents and Cerilliant certified spiking solutions through brand-name-restricted RFBs in April 2026. The Philadelphia procurement (micro purchase for Clean Thru Extraction Columns, due May 30) represents isolated municipal laboratory activity. Historical values for individual Texas procurements range from $25,000 to $226,000, suggesting moderate deal sizes typical of regional lab supply contracting. No set-aside restrictions or incumbent vendors are consistently identified across the opportunities, and all Texas purchases require extensive state-specific compliance certifications.